4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-005696
Chief Operating Officer acquired 650,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiBiase Mary Chief Operating Officer | 2025-02-12 | Grant or award | +650,000 | 1,140,980 | D |
Loading xslF345X05/wk-form4_1739567286.xml…